Codes / ICD10CM / C83.73

C83.73 Burkitt lymphoma, intra-abdominal lymph nodes

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Burkitt lymphoma, intra-abdominal lymph nodes
  • Medical term: Burkitt's lymphoma

Summary

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects B-cells in the lymphatic system. This subtype involves the lymph nodes located within the abdominal cavity. It is characterized by rapid tumor growth and is often associated with specific genetic and viral factors. Early diagnosis and treatment are critical due to its fast progression.

Causes

The exact causes of Burkitt lymphoma are not fully understood, but it is strongly linked to infection with the Epstein-Barr virus (EBV). Genetic mutations, particularly chromosomal translocations involving the MYC gene, are also key contributors to its development.

Risk Factors

  • Epstein-Barr virus (EBV) infection
  • Human immunodeficiency virus (HIV) infection
  • Weakened immune system from other conditions or treatments
  • Young age, especially in children and young adults
  • Geographic regions with high EBV prevalence, such as equatorial Africa

Symptoms

  • Rapidly growing, painless lymph node swelling in the abdomen
  • Abdominal pain or swelling
  • Fever
  • Night sweats
  • Unexplained weight loss
  • Fatigue
  • Possible bowel obstruction or organ compression if lymph nodes are enlarged

Diagnosis

Diagnosis involves a physical examination to assess abdominal swelling or organ enlargement, followed by imaging tests (e.g., CT or MRI) to identify tumor locations. A biopsy of affected tissue is performed to confirm the presence of cancerous cells and determine the specific subtype.

Treatment Options

Treatment typically involves intensive chemotherapy regimens, often combined with immunotherapy or targeted therapies. In some cases, surgery may be used to address complications like bowel obstruction. Radiation therapy is less commonly used but may be considered for localized disease.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for Burkitt lymphoma can be favorable, especially in younger patients. However, the aggressive nature of the disease requires close monitoring for recurrence. Follow-up care includes regular imaging and blood tests to detect any relapse early.

Complications

  • Bowel obstruction due to enlarged lymph nodes
  • Organ compression affecting kidney or liver function
  • Metastasis to other parts of the body
  • Treatment-related side effects, such as infection or organ toxicity

Lifestyle & Prevention

There are no specific lifestyle changes to prevent Burkitt lymphoma, as it is linked to viral and genetic factors. Maintaining a healthy immune system through general wellness practices may support overall health but does not reduce risk.

When to Seek Professional Help

Seek immediate medical attention if you experience persistent abdominal pain, unexplained swelling, or symptoms like fever and weight loss. Early evaluation is crucial for timely diagnosis and treatment.

Tips for Medical Coders

When coding for Burkitt lymphoma involving intra-abdominal lymph nodes, ensure the documentation specifies the anatomical location to support the use of code C83.73. Verify that the diagnosis aligns with the clinical findings and that any associated conditions (e.g., EBV infection) are documented if relevant to the case.

Book a walkthrough

C83.73 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.